BeStock  
Stocks › CGON

CG Oncology CGON

US equityMarket cap rank #1717
$79.47 −$2.43 (-2.97%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $79.50 +0.04%
Open$80.32
Prev close$81.90
Day range$79.21 – $83.16
Volume1.67M
Market cap$7.10B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.60M-3.7% YoY
Operating profit-$63.25M-23.7% YoY
Net profit-$56.89M-29.9% YoY
Diluted EPS-$0.64-12.3% YoY
Free cash flow-$48.82M-25.2% YoY
Operating cash flow-$47.71M

Revenue, last 8 quarters

$456.0KDec '24$52.0KMar '25$0.0Jun '25$1.7MSep '25$2.3MDec '25$1.1MMar '26$1.2MJun '26$1.6MSep '26

Net profit, last 8 quarters

$-31.8MDec '24$-34.5MMar '25$-41.4MJun '25$-43.8MSep '25$-41.3MDec '25$-60.2MMar '26$-79.1MJun '26$-56.9MSep '26

Diluted EPS by quarter

-0.48Dec '24-0.45Mar '25-0.54Jun '25-0.57Sep '25-0.51Dec '25-0.71Mar '26-0.90Jun '26-0.64Sep '26

Free cash flow by quarter

$-20.9MDec '24$-29.3MMar '25$-28.0MJun '25$-39.0MSep '25$-36.2MDec '25$-57.2MMar '26$-46.9MJun '26$-48.8MSep '26

Annual revenue

$10.4MFY21$191.0KFY22$204.0KFY23$1.1MFY24$4.0MFY25

Profitability & balance sheet

Gross margin-104.8%
Operating margin-4,293.5%
Net margin-3,851.1%
Return on equity-28.3%
Return on assets-26.7%
Return on invested capital-31.3%
Current ratio21.70
Liabilities / assets5.3%
Cash & investments$984.46M
Total debt$8.11M
Net cash (debt)$976.35M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.60M $1.16M $1.08M $4.04M $2.32M
Total Operating Revenue $1.60M $1.16M $1.08M $4.04M $2.32M
Cost of Revenue $2.67M $3.93M $2.96M $4.65M $3.07M
Gross Profit -$1.07M -$2.77M -$1.88M -$607,000.00 -$748,000.00
Operating Expense $62.18M $83.63M $64.51M $190.17M $47.95M
Selling and Admin Expenses $22.96M $28.98M $20.78M $73.53M $17.99M
-General & Admin Expense $22.96M $28.98M $20.78M $73.53M $17.99M
Research & Development $39.22M $54.66M $43.73M $116.64M $29.96M
Operating Profit -$63.25M -$86.40M -$66.39M -$190.77M -$48.70M
Net Non-Operating Interest Income (Expense) $6.42M $7.33M $6.29M $29.93M $7.44M
Non-Operating Interest Income $6.42M $7.33M $6.29M $29.93M $7.44M
Other Income (Expense) -$65,000.00 $16,000.00 -$101,000.00 -$152,000.00 -$53,000.00
Other Non-Operating Income (Expenses) -$65,000.00 $16,000.00 -$101,000.00 -$152,000.00 -$53,000.00
Pretax Profit -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Net Profit -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Profit from Continuing Operations -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Net Income to Parent Company -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Net Income to Common Stockholders -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Basic EPS -$0.64 -$0.90 -$0.71 -$2.08 -$0.51
Diluted EPS -$0.64 -$0.90 -$0.71 -$2.08 -$0.51

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.05B $1.09B $1.14B $791.59M $791.59M
Total Current Assets $1.01B $1.05B $1.10B $759.48M $759.48M
Cash and Cash Equivalents & Short-Term Investments $984.46M $1.03B $1.08B $742.16M $742.16M
-Cash and Cash Equivalents $28.25M $19.64M $33.70M $32.49M $32.49M
-Short Term Investments $956.21M $1.01B $1.04B $709.67M $709.67M
Receivables $666,000.00 $417,000.00 $1.28M $688,000.00 $688,000.00
-Accounts Receivable $666,000.00 $417,000.00 $1.28M $688,000.00 $688,000.00
Inventory $1.17M $1.00M $1.49M $1.57M $1.57M
Other Current Assets $21.44M $19.95M $23.13M $15.07M $15.07M
Total Non-Current Assets $38.94M $36.01M $33.12M $32.12M $32.12M
Net PPE $21.19M $20.44M $19.59M $19.57M $19.57M
-Gross PPE $25.15M $23.57M $21.88M $21.04M $21.04M
-Accumulated Depreciation -$3.96M -$3.13M -$2.29M -$1.47M -$1.47M
Goodwill and Other Intangible Assets $10.83M $10.84M $10.86M $10.87M $10.87M
-Goodwill $10.30M $10.30M $10.30M $10.30M $10.30M
-Other Intangible Assets $530,000.00 $545,000.00 $560,000.00 $575,000.00 $575,000.00
Other Non-Current Assets $6.92M $4.73M $2.68M $1.68M $1.68M
Total Liabilities $55.70M $56.54M $43.48M $38.99M $38.99M
Total Current Liabilities $46.43M $47.24M $35.22M $30.84M $30.84M
Payables $9.77M $12.73M $8.24M $5.71M $5.71M
-Accounts Payable $9.77M $12.73M $8.24M $5.71M $5.71M
Current Accrued Expenses $26.68M $26.27M $20.95M $14.90M $14.90M
Short-Term Debt and Capital Lease Obligation $1.13M $985,000.00 $1.07M $915,000.00 $915,000.00
-Current Capital Lease Obligation $1.13M $985,000.00 $1.07M $915,000.00 $915,000.00
Current Deferred Liabilities $29,000.00 $226,000.00 $254,000.00 $286,000.00 $286,000.00
Other Current Liabilities $1.56M $1.45M $1.71M $802,000.00 $802,000.00
Total Non-Current Liabilities $9.27M $9.30M $8.27M $8.15M $8.15M
Long Term Debt and Capital Lease Obligation $8.11M $7.83M $6.51M $6.11M $6.11M
-Long Term Debt $3.00M $3.00M $3.00M $3.00M $3.00M
-Long Term Capital Lease Obligation $5.11M $4.83M $3.51M $3.11M $3.11M
Non-Current Deferred Liabilities $307,000.00 $307,000.00 $307,000.00 $307,000.00 $307,000.00
Other Non-Current Liabilities $855,000.00 $1.16M $1.45M $1.74M $1.74M
Total Equity $990.97M $1.03B $1.09B $752.60M $752.60M
Stockholders' Equity $990.97M $1.03B $1.09B $752.60M $752.60M
Capital Stock $9,000.00 $9,000.00 $9,000.00 $8,000.00 $8,000.00
-Common Stock $9,000.00 $9,000.00 $9,000.00 $8,000.00 $8,000.00
Additional Paid-In Capital $1.57B $1.55B $1.53B $1.13B $1.13B
Retained Earnings -$575.13M -$518.23M -$439.18M -$378.98M -$378.98M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$47.71M -$46.41M -$56.94M -$132.35M -$36.22M
Net cash flow from continuing operations -$47.71M -$46.41M -$56.94M -$132.35M -$36.22M
Net Income from Continuing Operations -$56.89M -$79.06M -$60.20M -$161.00M -$41.31M
Depreciation & Depletion & Amortization $1.16M $850,000.00 $841,000.00 $1.45M $849,000.00
Other Non-Cash Items $110,000.00 $71,000.00 $59,000.00 -$734,000.00 $89,000.00
Change in Working Capital -$5.82M $14.38M -$5.78M $2.28M -$3.98M
-Change in Receivables -$249,000.00 $858,000.00 -$587,000.00 -$320,000.00 -$301,000.00
-Change in Inventory -$162,000.00 $490,000.00 $72,000.00 -$444,000.00 -$64,000.00
-Change in Prepaid Assets -$1.49M $3.18M -$8.07M -$1.90M -$1.81M
-Change in Payables and Accrued Expense -$974,000.00 $12.23M $4.13M $7.01M $252,000.00
-Change in Other Current Assets -$2.62M -$2.05M -$998,000.00 -$1.58M -$1.56M
-Change in Other Current Liabilities -$324,000.00 -$325,000.00 -$329,000.00 -$487,000.00 -$496,000.00
Net cash flow from investing $46.04M $30.43M -$334.85M -$245.82M -$75.51M
Net Cash Flow from Continuing Investing Activities $46.04M $30.43M -$334.85M -$245.82M -$75.51M
Net PPE Purchase and Sale -$1.12M -$468,000.00 -$304,000.00 -$134,000.00 -$7,000.00
Net Investment Purchase and Sale $47.15M $30.90M -$334.54M -$223.72M -$75.50M
Financing Cash Flow $10.28M $1.92M $393.00M $153.59M $99.07M
Net Cash Flow from Continuing Financing Activities $10.28M $1.92M $393.00M $153.59M $99.07M
Net Common Stock Issuance $0.00 $0.00 $391.55M $147.45M $98.45M
Proceeds from Stock Option Exercised $10.29M $2.08M $1.67M $6.46M $656,000.00
Net Other Financing Charges -$3,000.00 -$159,000.00 -$221,000.00 -$316,000.00 -$39,000.00
Ending Cash Balance $28.25M $19.64M $33.70M $32.49M $32.49M
Net Change in Cash $8.61M -$14.06M $1.21M -$224.58M -$12.66M
Beginning Cash Balance $19.64M $33.70M $32.49M $257.07M $45.15M
Free Cash Flow -$48.82M -$46.88M -$57.25M -$132.48M -$36.22M
Net Business Purchase and Sale – – – -$21.97M $0.00
Net Issuance Payments Of Debt – – – $0.00 $0.00
Net Preferred Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on CGON.

Sign in to join the discussion.

Scroll to Top